Document Detail


Transgenic animal models of cardiovascular disease.
MedLine Citation:
PMID:  1369120     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Transgenic experimentation has become a crucial part of hypertension and atherosclerosis research, and is growing more important in several other areas of cardiovascular disease. It has recently made a particular contribution to understanding the role of the renin-angiotensin system in controlling hypertension. The study of blood pressure regulation, cardiac hypertrophy, atherogenesis and thrombosis are also benefiting from the transgenic approach.
Authors:
G Barrett; J J Mullins
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current opinion in biotechnology     Volume:  3     ISSN:  0958-1669     ISO Abbreviation:  Curr. Opin. Biotechnol.     Publication Date:  1992 Dec 
Date Detail:
Created Date:  1993-02-25     Completed Date:  1993-02-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9100492     Medline TA:  Curr Opin Biotechnol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  637-40     Citation Subset:  B    
Affiliation:
Centre for Genome Research, University of Edinburgh, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Animals, Genetically Modified*
Apolipoprotein A-I / metabolism
Arteriosclerosis / genetics,  physiopathology
Blood Pressure
Cardiomegaly / genetics,  physiopathology
Cardiovascular Diseases / genetics,  physiopathology*
Cholesterol, HDL / blood
Disease Models, Animal
Humans
Hypertension / genetics,  physiopathology
Mice
Mice, Transgenic
Renin / genetics
Renin-Angiotensin System / genetics
Chemical
Reg. No./Substance:
0/Apolipoprotein A-I; 0/Cholesterol, HDL; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Molecular cytogenetics: diagnosis and prognostic assessment.
Next Document:  Immunotherapy of AIDS.